PMC:7536954 / 508-680 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":18,"end":46},"obj":"Disease"},{"id":"T12","span":{"begin":27,"end":46},"obj":"Disease"},{"id":"T13","span":{"begin":48,"end":51},"obj":"Disease"},{"id":"T14","span":{"begin":137,"end":155},"obj":"Disease"},{"id":"T15","span":{"begin":150,"end":155},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0007915"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0004670"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0007915"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0016474"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0004670"}],"text":"ons, particularly systemic lupus erythematosus (SLE), may represent a contraindication to the use of TNF‐α inhibitors due to the risk of drug‐induced lupus. 1 Thus, the un"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":68,"end":69},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T10","span":{"begin":101,"end":104},"obj":"http://purl.obolibrary.org/obo/PR_000000134"}],"text":"ons, particularly systemic lupus erythematosus (SLE), may represent a contraindication to the use of TNF‐α inhibitors due to the risk of drug‐induced lupus. 1 Thus, the un"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":107,"end":117},"obj":"Chemical"},{"id":"T6","span":{"begin":137,"end":141},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"ons, particularly systemic lupus erythematosus (SLE), may represent a contraindication to the use of TNF‐α inhibitors due to the risk of drug‐induced lupus. 1 Thus, the un"}

{"project":"LitCovid-PubTator","denotations":[{"id":"31","span":{"begin":101,"end":106},"obj":"Gene"},{"id":"40","span":{"begin":18,"end":46},"obj":"Disease"},{"id":"41","span":{"begin":48,"end":51},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Gene:7124"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:D008180"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D008180"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ons, particularly systemic lupus erythematosus (SLE), may represent a contraindication to the use of TNF‐α inhibitors due to the risk of drug‐induced lupus. 1 Thus, the un"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":18,"end":46},"obj":"Phenotype"},{"id":"T9","span":{"begin":48,"end":51},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002725"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002725"}],"text":"ons, particularly systemic lupus erythematosus (SLE), may represent a contraindication to the use of TNF‐α inhibitors due to the risk of drug‐induced lupus. 1 Thus, the un"}